563 related articles for article (PubMed ID: 32920752)
1. COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy.
Verma YK; Verma R; Tyagi N; Behl A; Kumar S; Gangenahalli GU
Stem Cell Rev Rep; 2021 Feb; 17(1):113-131. PubMed ID: 32920752
[TBL] [Abstract][Full Text] [Related]
2. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.
Cheng X; Jiang M; Long L; Meng J
Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217
[No Abstract] [Full Text] [Related]
3. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
Zayed M; Iohara K
Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential.
Xiong J; Bao L; Qi H; Feng Z; Shi Y
Curr Stem Cell Res Ther; 2021; 16(2):105-108. PubMed ID: 32479246
[TBL] [Abstract][Full Text] [Related]
5. Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs.
Jamshidi E; Babajani A; Soltani P; Niknejad H
Stem Cell Rev Rep; 2021 Feb; 17(1):176-192. PubMed ID: 33432484
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics.
Yadav P; Vats R; Bano A; Bhardwaj R
Life Sci; 2020 Dec; 263():118588. PubMed ID: 33049279
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K
Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges.
Pourgholaminejad A; Pahlavanneshan S; Basiri M
Scand J Immunol; 2022 Feb; 95(2):e13131. PubMed ID: 34936112
[TBL] [Abstract][Full Text] [Related]
9. 'Primed' Mesenchymal Stem Cells: a Potential Novel Therapeutic for COVID19 Patients.
Raza SS; Seth P; Khan MA
Stem Cell Rev Rep; 2021 Feb; 17(1):153-162. PubMed ID: 32592163
[TBL] [Abstract][Full Text] [Related]
10. Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments.
Gurunathan S; Kang MH; Kim JH
Front Immunol; 2021; 12():716407. PubMed ID: 34394121
[TBL] [Abstract][Full Text] [Related]
11. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
Can A; Coskun H
Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19.
Rocha JLM; de Oliveira WCF; Noronha NC; Dos Santos NCD; Covas DT; Picanço-Castro V; Swiech K; Malmegrim KCR
Stem Cell Rev Rep; 2021 Feb; 17(1):71-93. PubMed ID: 32895900
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future.
Golchin A; Seyedjafari E; Ardeshirylajimi A
Stem Cell Rev Rep; 2020 Jun; 16(3):427-433. PubMed ID: 32281052
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action.
Sadeghi S; Soudi S; Shafiee A; Hashemi SM
Life Sci; 2020 Dec; 262():118493. PubMed ID: 32979360
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities.
Moradinasab S; Pourbagheri-Sigaroodi A; Zafari P; Ghaffari SH; Bashash D
Int Immunopharmacol; 2021 Aug; 97():107694. PubMed ID: 33932694
[TBL] [Abstract][Full Text] [Related]
16. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR
J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449
[TBL] [Abstract][Full Text] [Related]
17. Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19.
Cai Q; Yin F; Hao L; Jiang W
Stem Cells Dev; 2021 May; 30(9):459-472. PubMed ID: 33715385
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review.
Li J; Wang X; Li N; Jiang Y; Huang H; Wang T; Lin Z; Xiong N
Curr Gene Ther; 2020; 20(4):285-288. PubMed ID: 32867652
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19.
Chaudhary JK; Saini D; Chaudhary PK; Maurya A; Verma GK; Gupta AK; Roshan R; Vats TK; Garg N; Yadav D; Kant N; Meena AK; Mirza-Shariff AA
Cells; 2022 Jul; 11(14):. PubMed ID: 35883618
[TBL] [Abstract][Full Text] [Related]
20. Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients.
Esquivel D; Mishra R; Soni P; Seetharaman R; Mahmood A; Srivastava A
Stem Cell Rev Rep; 2021 Feb; 17(1):144-152. PubMed ID: 32740890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]